Nuclear membrane disruption in neurodegenerative diseases: Emerging perspectives
Authors:
Open Access
- 27 January 2026
- journal article
- Published by Wolters Kluwer Health in Neural Regeneration Research
- Vol. 21 (10) , 4729-4733
Abstract
The nucleus, as the largest organelle within the cell, serves as the central hub for storing, replicating, and transcribing genetic information, thereby orchestrating vital cellular processes. In eukaryotic cells, the nuclear membrane is composed of several structural components: the outer and inner nuclear membranes, the nuclear pore complexes, and the underlying nuclear lamina, which together preserve the stability of the intracellular environment. Neurodegenerative disorders, such as Alzheimer’s disease and related dementias, are characterized by the gradual degeneration and loss of neuronal structure and function in the central nervous system. Growing evidence suggests that alterations in nuclear envelope architecture are closely associated with the onset and progression of these diseases. This article summarizes the information, focusing on the regulators of the cell nuclear membrane, as well as its pathophysiological processes and regulatory mechanisms in neurodegenerative diseases. Moreover, this paper discusses related research advances that provide novel insights into a deeper understanding of the nuclear membrane in disease progression and its potential as a therapeutic target.Keywords
This publication has 102 references indexed in Scilit:
- Are lecanemab and donanemab disease‐modifying therapies?Alzheimer's & Dementia, 2024
- Scaffold, mechanics and functions of nuclear laminsFEBS Letters, 2023
- Pyroptosis in Alzheimer’s disease: cell type-specific activation in microglia, astrocytes and neuronsActa Neuropathologica, 2022
- Longitudinal Clinical and Biological Characteristics in Juvenile‐Onset Huntington's DiseaseMovement Disorders, 2022
- Nuclear Envelope and Nuclear Pore Complexes in Neurodegenerative Diseases—New Perspectives for Therapeutic InterventionsMolecular Neurobiology, 2020
- Diagnosis and Treatment of Parkinson DiseaseJAMA, 2020
- Altered Nup153 Expression Impairs the Function of Cultured Hippocampal Neural Stem Cells Isolated from a Mouse Model of Alzheimer’s DiseaseMolecular Neurobiology, 2019
- Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to NeurodegenerationMolecular Neurobiology, 2018
- Mechanical Role of Nesprin-1-Mediated Nucleus–Actin Filament Binding in Cyclic Stretch-Induced Fibroblast ElongationCellular and Molecular Bioengineering, 2017
- Ranbp2 haploinsufficiency mediates distinct cellular and biochemical phenotypes in brain and retinal dopaminergic and glia cells elicited by the Parkinsonian neurotoxin, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Cellular and Molecular Life Sciences, 2012